Connect with us

Headlines of The Day

Metropolis Healthcare posts Rs. 58 crore consolidated net profit in Q2FY22

“We are pleased to share that we have continued the strong business momentum with recording robust revenue along with profitability during Q2FY22. This strong performance has been on the back of growth in sustainable non-covid revenue, increased patient visits & tests and increased contribution from specialized tests. With economy now strongly recovering from the pandemic, we expect our non-covid business to continue grow sustainably. Our recently acquired Hitech Diagnostics will further enable us to scale up our business, improve the B2C revenue contribution and increase our market penetration by catering to the value segment of the market.” – Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd.

Key highlights of the results

  • Patient visits increased by 25% on YoY basis to 3.3 Mn.
  • No. of tests increased by 29% on YoY basis to 6.2 Mn.
  • Non-Covid Home Visits Revenue increased by 17% on YoY basis to Rs. 26 Crs.
  • Revenue contribution from specialised tests (non-covid) increased to 43% in Q2FY22 from 39% in Q2FY21
In INR Crs. Q2FY22 Q2FY21
Revenue from Operations 302.6 288.4
EBITDA before CSR & ESOP 93.2 94.9
Reported Profit After Tax 58.4 60.5
Reported PAT Margin (%) 19.3% 21.0%

For report please click here.
MB Bureau